WBC: 6.7RBC: 3.41HTC: 32.9PLATELETS: 307Free Light Chains: ALL NORMALKappa: 1.44Lambda: 1.32Ratio: 1.08M-Spike: 0.3 Dropped from 0.5 in April after just a couple …
WBC: 8.7HTC: 39.3PLATELETS: 288ANC: 70*Kappa: 18.93*Lambda: 22.34*Ratio: .85Thankfully, his M-Spike remains at .3! His oncologist is very pleased.
Normal levels of serum free light chains are:
• Kappa: 3.3–19.4 mg/L
• Lambda: 5.71–26.3 mg/L
• Kappa/lambda ratio: 0.26–1.65
His December Numbers Were:
Thankfully, his M-Spike remains at .3! His oncologist is very pleased.
Tulane is sending me the other numbers via mail.
WBC: 6.3HTC: 38PLATELETS: 189ANC: 67Light Chains:Kappa- 18.86Lambda- 19.72Ratio- 0.96M SPIKE NOT OBSERVED 0.3
We had a wonderful St. Patrick’s Day and celebrated accordingly. Dom’s Light Chains continue to drop. We’re absolutely tickled. Thank you for the prayers and positive thoughts, gang!WBC: 5.4HTC: 40.6PLATELETS: 192…
Thanks for all of the prayers and good vibes!WBC: 6.5HTC: 36.1PLATELETS: 186ANC: 56LIGHT CHAINS:Kappa: 19.21Lamda: 18.72Ratio: 1.03ZERO M-SPIKE!!!!!!!!!!!!!!!!!
Finally got to take a look at Dom’s Light Chains from May. I was tickled to see the numbers dropping, but was concerned about his Ratio shooting up. After some research, I think that this is probably wonderful news. Looking forward to discussing this with his doctor in August. Link at the bottom.
Kappa 3.3 – 19.4
Labda 5.71 – 26.3
Ratio 0.26 – 1.65
(A Downward Trend in all of these is GOOD.)
Dom’s Light Chains:
March ’13: 19.19
Oct. ’13 14.92
Jan ’14 13.82
May ‘14 7.49
March ’13 19.21
Oct. ’13 16.77
Jan ’14 15.69
May ‘14 0.63
March ’13 1.00
Oct. ’13 0.89
Jan ’14 0.88
May ‘14 11.89
Heavy/Light Chain Ratios May Be A Prognostic Marker For Myeloma Patients
The results of a small Spanish study indicate that heavy/light chain ratios may be a prognostic marker for myeloma patients.
Specifically, the Spanish researchers found that multiple myeloma patients who experienced elevated heavy/light chain ratios after achieving complete remission following a stem cell transplant had longer progression-free and overall survival rates than patients who did not experience elevated heavy/light chain ratios.
According to the study investigators, these results show for the first time the association between a heavy/light chain ratio and sustained remission in myeloma patients.
We’ll be getting his M-Spike and other numbers this week:
Hi gang-Got Dom’s M-Spike and Light Chain Results:M-SPIKE: ZEROKappa: 14.92Labda: 16.77Ratio: 0.89(All Normal)He has now been in complete remission for 51 MonthsYIPPEE!!!!!!!!!!!!!!!!!!!!
Multiple myeloma (MM) is a clonal B-cell disease of slowly proliferating plasma cells, accompanied by monoclonal protein production and lytic bone lesions. Up to 50 per cent of newly diagnosed patients have a decrease in creatine clearance and 20 per cent of Multiple Myeloma patients Kidney failure occurs as a consequence of elevated calcium levels in the blood or when the kidneys are overloaded with protein.
Normally, the kidneys remove wastes, extra fluids, and minerals from the blood. But when they stop functioning, harmful wastes build up and this can cause other complications such as high blood pressure. In addition, the disease can cause too much calcium to leave your bones and head into your bloodstream, where it can put a strain on your kidneys.
When kidney failure is irreversible, patients undergo a procedure known as dialysis to help their bodies filter blood. Dialysis removes the extra fluid and waste from the blood, and it can prolong the overall survival for multiple myeloma patients.
The incidence of renal failure certainly rises as the tumor load increases, but it is the underlying tumor burden that ultimately determines survival. Therefore, treatment of myeloma to achieve reduction might also reduce the occurrence of kidney failure.
The most common test used as a follow-up to abnormal routine tests and to help diagnose the disease include Protein and Immunofixation Electrophoresis. This test is used to diagnose and monitor multiple myeloma. Protein electrophoresis separates the proteins in a blood or urine sample into several groups based on their electrical charge and size. In most patients with multiple myeloma, large amounts of an abnormal immunoglobulin protein (M-protein) will show up as a large peak on the electrophoresis graph.
Usually, both a blood and a urine sample will be tested during the diagnosis of multiple myeloma because some proteins, such as the Bence Jones proteins (free light chains), may not show up in significant quantities in blood samples, while those with only intact immunoglobulins may not have the abnormal protein in urine.
Bence Jones protein (free light chains) can be detected in the urine of some patients with multiple myeloma. Cancer screening exams are important medical tests done when you’re at risk but don’t have symptoms. They help find cancer at its earliest stage, when the chances for successful treatment are best.
—Dr Bharat Vaswani, Yashoda Hospital